ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil
Expert Review of Pharmacoeconomics & Outcomes Research
◽
10.1080/14737167.2021.1909478
◽
2021
◽
pp. 1-10
Author(s):
Carlos Henrique Botelho
◽
Maria Del Pilar Estevez-Diz
◽
Alessandro Gonçalves Campolina
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Early Breast Cancer
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
Related Documents
Cited By
References
58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer
Annals of Oncology
◽
10.1016/j.annonc.2021.03.072
◽
2021
◽
Vol 32
◽
pp. S45
Author(s):
X. Guan
◽
H-C. Li
◽
Q-J. Chen
◽
B. Hua
◽
J-J. Li
◽
...
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Early Breast Cancer
◽
Cost Effectiveness Analysis
◽
Chinese Patients
◽
Trastuzumab Emtansine
◽
Her2 Positive
◽
Effectiveness Analysis
Download Full-text
CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA
Value in Health
◽
10.1016/j.jval.2019.09.048
◽
2019
◽
Vol 22
◽
pp. S405-S406
Author(s):
X. Guan
◽
H. Li
◽
Q. Chen
◽
C. Hao
◽
J. Li
◽
...
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
High Risk
◽
Early Breast Cancer
◽
Adjuvant Treatment
◽
Cost Effectiveness Analysis
◽
Her2 Positive
◽
Risk Of Recurrence
◽
Effectiveness Analysis
Download Full-text
Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China
Clinical Drug Investigation
◽
10.1007/s40261-019-00842-0
◽
2019
◽
Vol 40
(1)
◽
pp. 25-32
◽
Cited By ~ 2
Author(s):
Xiaoxia Wei
◽
Hong Sun
◽
Jie Zhuang
◽
Xiuhua Weng
◽
Bin Zheng
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Cost Effectiveness
◽
Postmenopausal Women
◽
Endocrine Therapy
◽
Early Breast Cancer
◽
Cost Effectiveness Analysis
◽
Pharmacogenetic Testing
◽
Effectiveness Analysis
◽
Estrogen Receptor Positive
Download Full-text
Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective
PLoS ONE
◽
10.1371/journal.pone.0172731
◽
2017
◽
Vol 12
(3)
◽
pp. e0172731
◽
Cited By ~ 6
Author(s):
Caroline S. Clarke
◽
Rachael M. Hunter
◽
Ian Shemilt
◽
Victoria Serra-Sastre
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Early Breast Cancer
◽
Cost Effectiveness Analysis
◽
Adjuvant Trastuzumab
◽
Effectiveness Analysis
◽
Payer Perspective
Download Full-text
Cost Effectiveness Analysis of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in Early Breast Cancer Patients
Value in Health
◽
10.1016/j.jval.2014.08.2306
◽
2014
◽
Vol 17
(7)
◽
pp. A640
◽
Cited By ~ 3
Author(s):
A. Vaidya
◽
P. Vaidya
◽
B. Both
◽
C. Brew-Graves
◽
J. Vaidya
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Cancer Patients
◽
Early Breast Cancer
◽
Intraoperative Radiotherapy
◽
Cost Effectiveness Analysis
◽
Breast Cancer Patients
◽
Effectiveness Analysis
◽
Radiotherapy Alone
Download Full-text
Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer
PharmacoEconomics
◽
10.2165/11588340-000000000-00000
◽
2011
◽
Vol 29
(5)
◽
pp. 415-432
◽
Cited By ~ 36
Author(s):
Peter S. Hall
◽
Claire Hulme
◽
Christopher McCabe
◽
Yemi Oluboyede
◽
Jeff Round
◽
...
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Early Breast Cancer
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT THERAPY WITH TRASTUZUMAB FOR HER2-POSITIVE EARLY BREAST CANCER IN POLISH SETTING
Value in Health
◽
10.1016/s1098-3015(10)68918-8
◽
2007
◽
Vol 10
(3)
◽
pp. A125
◽
Cited By ~ 1
Author(s):
E Orlewska
◽
T Pienkowski
◽
K Drosik
◽
M Gyldmark
◽
R Aultman
◽
...
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Adjuvant Therapy
◽
Early Breast Cancer
◽
Cost Effectiveness Analysis
◽
Her2 Positive
◽
Effectiveness Analysis
Download Full-text
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial
Clinical Drug Investigation
◽
10.1007/s40261-021-01114-6
◽
2022
◽
Author(s):
C. Louwrens Braal
◽
Anne Kleijburg
◽
Agnes Jager
◽
Stijn L. W. Koolen
◽
Ron H. J. Mathijssen
◽
...
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Therapeutic Drug Monitoring
◽
Early Breast Cancer
◽
Drug Monitoring
◽
Cost Effectiveness Analysis
◽
Adjuvant Tamoxifen
◽
Therapeutic Drug
◽
Effectiveness Analysis
Download Full-text
Cost-Effectiveness Analysis of Adjuvant Hormonal Treatments for Women with Postmenopausal Hormone-Receptor Positive Early Breast Cancer in the Korean Context
Journal of Breast Cancer
◽
10.4048/jbc.2010.13.3.286
◽
2010
◽
Vol 13
(3)
◽
pp. 286
◽
Cited By ~ 4
Author(s):
Hye-Jae Lee
◽
Tae-Jin Lee
◽
Bong-Min Yang
◽
Junwon Min
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Early Breast Cancer
◽
Hormone Receptor
◽
Cost Effectiveness Analysis
◽
Postmenopausal Hormone
◽
Hormone Receptor Positive
◽
Effectiveness Analysis
◽
Hormonal Treatments
Download Full-text
PCN32 COST-EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN AS INITIAL ADJUVANT THERAPY IN HORMONE-RECEPTOR POSITIVE POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER IN THE UK
Value in Health
◽
10.1016/s1098-3015(10)67270-1
◽
2005
◽
Vol 8
(6)
◽
pp. A43
Author(s):
J Karnon
◽
TE Delea
◽
NL Papo
◽
V Barghout
◽
SK Thomas
◽
...
Keyword(s):
Breast Cancer
◽
Cost Effectiveness
◽
Adjuvant Therapy
◽
Postmenopausal Women
◽
Early Breast Cancer
◽
Hormone Receptor
◽
Cost Effectiveness Analysis
◽
Hormone Receptor Positive
◽
Effectiveness Analysis
◽
The Uk
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close